Titre : Protéine Wnt-5a

Protéine Wnt-5a : Questions médicales fréquentes

Termes MeSH sélectionnés :

Behavior, Addictive
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéine Wnt-5a : Questions médicales les plus fréquentes", "headline": "Protéine Wnt-5a : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéine Wnt-5a : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-28", "dateModified": "2025-04-23", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéine Wnt-5a" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines de type Wingless", "url": "https://questionsmedicales.fr/mesh/D051153", "about": { "@type": "MedicalCondition", "name": "Protéines de type Wingless", "code": { "@type": "MedicalCode", "code": "D051153", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.984" } } }, "about": { "@type": "MedicalCondition", "name": "Protéine Wnt-5a", "alternateName": "Wnt-5a Protein", "code": { "@type": "MedicalCode", "code": "D000071818", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Soon B Hwang", "url": "https://questionsmedicales.fr/author/Soon%20B%20Hwang", "affiliation": { "@type": "Organization", "name": "Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Chonbuk National University, Iksan, South Korea sbhwang@jbnu.ac.kr." } }, { "@type": "Person", "name": "Rui Zhou", "url": "https://questionsmedicales.fr/author/Rui%20Zhou", "affiliation": { "@type": "Organization", "name": "Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China." } }, { "@type": "Person", "name": "Xiang-Dong Li", "url": "https://questionsmedicales.fr/author/Xiang-Dong%20Li", "affiliation": { "@type": "Organization", "name": "Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China lixd@ioz.ac.cn." } }, { "@type": "Person", "name": "Richa Mishra", "url": "https://questionsmedicales.fr/author/Richa%20Mishra", "affiliation": { "@type": "Organization", "name": "Chemical Biology Laboratory, School of Basic Sciences, Indian Institute of Technology Bhubaneswar, Bhubaneswar, Odisha, India." } }, { "@type": "Person", "name": "Soumendra Rana", "url": "https://questionsmedicales.fr/author/Soumendra%20Rana", "affiliation": { "@type": "Organization", "name": "Chemical Biology Laboratory, School of Basic Sciences, Indian Institute of Technology Bhubaneswar, Bhubaneswar, Odisha, India." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Technological Addictions.", "datePublished": "2022-08-01", "url": "https://questionsmedicales.fr/article/36055740", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.psc.2022.04.007" } }, { "@type": "ScholarlyArticle", "name": "Effects of decision making and impulsivity on the addictive features of non-suicidal self-injury behaviors in adolescents with depressive disorder.", "datePublished": "2024-10-18", "url": "https://questionsmedicales.fr/article/39425107", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12888-024-06121-3" } }, { "@type": "ScholarlyArticle", "name": "The association between traumatic experiences and substance and behavioral addictions in late adolescence: A role for PTSD and cPTSD as potential mediators.", "datePublished": "2023-10-21", "url": "https://questionsmedicales.fr/article/37897840", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jpsychires.2023.10.023" } }, { "@type": "ScholarlyArticle", "name": "Thinking beyond cut-off scores in the assessment of potentially addictive behaviors: A brief illustration in the context of binge-watching.", "datePublished": "2023-06-30", "url": "https://questionsmedicales.fr/article/37384565", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1556/2006.2023.00032" } }, { "@type": "ScholarlyArticle", "name": "Cracking the code: unveiling the nexus between atopic dermatitis and addictive behavior: a cross-sectional exploration of risk factors.", "datePublished": "2024-03-14", "url": "https://questionsmedicales.fr/article/38485839", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00403-024-02841-4" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Protéines et peptides de signalisation intercellulaire", "item": "https://questionsmedicales.fr/mesh/D036341" }, { "@type": "ListItem", "position": 4, "name": "Protéines de type Wingless", "item": "https://questionsmedicales.fr/mesh/D051153" }, { "@type": "ListItem", "position": 5, "name": "Protéine Wnt-5a", "item": "https://questionsmedicales.fr/mesh/D000071818" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéine Wnt-5a - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéine Wnt-5a", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Protéine Wnt-5a", "description": "Comment diagnostiquer une anomalie de Wnt-5a ?\nQuels tests sont utilisés pour mesurer Wnt-5a ?\nWnt-5a est-il lié à des maladies spécifiques ?\nPeut-on détecter Wnt-5a dans le sang ?\nQuels biomarqueurs sont associés à Wnt-5a ?", "url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Behavior,+Addictive&page=6#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Protéine Wnt-5a", "description": "Quels symptômes sont liés à une dysrégulation de Wnt-5a ?\nWnt-5a influence-t-il le cancer ?\nY a-t-il des signes cliniques de dysfonction de Wnt-5a ?\nWnt-5a affecte-t-il le système nerveux ?\nQuels effets sur la peau sont liés à Wnt-5a ?", "url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Behavior,+Addictive&page=6#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Protéine Wnt-5a", "description": "Peut-on prévenir les anomalies de Wnt-5a ?\nY a-t-il des facteurs environnementaux affectant Wnt-5a ?\nComment le mode de vie influence-t-il Wnt-5a ?\nLes suppléments nutritionnels aident-ils Wnt-5a ?\nLa gestion du stress influence-t-elle Wnt-5a ?", "url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Behavior,+Addictive&page=6#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Protéine Wnt-5a", "description": "Comment traiter les anomalies de Wnt-5a ?\nY a-t-il des médicaments ciblant Wnt-5a ?\nLa thérapie génique peut-elle aider Wnt-5a ?\nQuels traitements sont efficaces contre le cancer lié à Wnt-5a ?\nDes essais cliniques existent-ils pour Wnt-5a ?", "url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Behavior,+Addictive&page=6#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Protéine Wnt-5a", "description": "Quelles complications sont liées à Wnt-5a ?\nWnt-5a peut-il causer des troubles métaboliques ?\nY a-t-il des risques de récidive de cancer avec Wnt-5a ?\nWnt-5a influence-t-il la réponse immunitaire ?\nDes complications neurologiques sont-elles possibles avec Wnt-5a ?", "url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Behavior,+Addictive&page=6#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Protéine Wnt-5a", "description": "Quels sont les facteurs de risque pour Wnt-5a ?\nL'âge influence-t-il Wnt-5a ?\nLe tabagisme affecte-t-il Wnt-5a ?\nY a-t-il un lien entre l'alimentation et Wnt-5a ?\nLe stress chronique impacte-t-il Wnt-5a ?", "url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Behavior,+Addictive&page=6#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie de Wnt-5a ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses de tissus peuvent être utilisés pour évaluer les niveaux de Wnt-5a." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour mesurer Wnt-5a ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des dosages ELISA et des techniques de Western blot sont couramment utilisés." } }, { "@type": "Question", "name": "Wnt-5a est-il lié à des maladies spécifiques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies de Wnt-5a sont associées à des cancers et des maladies auto-immunes." } }, { "@type": "Question", "name": "Peut-on détecter Wnt-5a dans le sang ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux de Wnt-5a peuvent être mesurés dans le sérum sanguin." } }, { "@type": "Question", "name": "Quels biomarqueurs sont associés à Wnt-5a ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "D'autres protéines de la voie Wnt, comme Wnt-1 et β-caténine, peuvent être des biomarqueurs." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une dysrégulation de Wnt-5a ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies de développement, des troubles immunitaires et des cancers peuvent survenir." } }, { "@type": "Question", "name": "Wnt-5a influence-t-il le cancer ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une expression anormale de Wnt-5a est liée à la progression de certains cancers." } }, { "@type": "Question", "name": "Y a-t-il des signes cliniques de dysfonction de Wnt-5a ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des malformations congénitales et des troubles de la croissance peuvent être observés." } }, { "@type": "Question", "name": "Wnt-5a affecte-t-il le système nerveux ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, Wnt-5a joue un rôle dans le développement neuronal et peut affecter la neurogenèse." } }, { "@type": "Question", "name": "Quels effets sur la peau sont liés à Wnt-5a ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies de Wnt-5a peuvent entraîner des troubles cutanés et des cancers de la peau." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies de Wnt-5a ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par une bonne santé maternelle et des soins prénatals appropriés." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux affectant Wnt-5a ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines et à des perturbateurs endocriniens peut influencer Wnt-5a." } }, { "@type": "Question", "name": "Comment le mode de vie influence-t-il Wnt-5a ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée, peut soutenir la régulation de Wnt-5a." } }, { "@type": "Question", "name": "Les suppléments nutritionnels aident-ils Wnt-5a ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certains suppléments, comme les acides gras oméga-3, peuvent moduler l'expression de Wnt-5a." } }, { "@type": "Question", "name": "La gestion du stress influence-t-elle Wnt-5a ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gestion du stress peut avoir un impact positif sur la régulation de Wnt-5a." } }, { "@type": "Question", "name": "Comment traiter les anomalies de Wnt-5a ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies ciblées et des traitements immunologiques peuvent être envisagés." } }, { "@type": "Question", "name": "Y a-t-il des médicaments ciblant Wnt-5a ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des inhibiteurs de la voie Wnt sont en développement pour traiter certains cancers." } }, { "@type": "Question", "name": "La thérapie génique peut-elle aider Wnt-5a ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est explorée pour corriger les anomalies de Wnt-5a dans certaines conditions." } }, { "@type": "Question", "name": "Quels traitements sont efficaces contre le cancer lié à Wnt-5a ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements combinés de chimiothérapie et d'immunothérapie montrent des résultats prometteurs." } }, { "@type": "Question", "name": "Des essais cliniques existent-ils pour Wnt-5a ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, plusieurs essais cliniques évaluent des traitements ciblant la voie Wnt-5a." } }, { "@type": "Question", "name": "Quelles complications sont liées à Wnt-5a ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des malformations congénitales et des cancers avancés." } }, { "@type": "Question", "name": "Wnt-5a peut-il causer des troubles métaboliques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une dysrégulation de Wnt-5a peut contribuer à des troubles métaboliques." } }, { "@type": "Question", "name": "Y a-t-il des risques de récidive de cancer avec Wnt-5a ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une expression anormale de Wnt-5a est associée à un risque accru de récidive." } }, { "@type": "Question", "name": "Wnt-5a influence-t-il la réponse immunitaire ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, Wnt-5a peut moduler la réponse immunitaire, affectant la susceptibilité aux infections." } }, { "@type": "Question", "name": "Des complications neurologiques sont-elles possibles avec Wnt-5a ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies de Wnt-5a peuvent entraîner des complications neurologiques." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour Wnt-5a ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des prédispositions génétiques et des expositions environnementales." } }, { "@type": "Question", "name": "L'âge influence-t-il Wnt-5a ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge peut affecter l'expression de Wnt-5a et son rôle dans diverses pathologies." } }, { "@type": "Question", "name": "Le tabagisme affecte-t-il Wnt-5a ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut altérer l'expression de Wnt-5a, augmentant le risque de cancer." } }, { "@type": "Question", "name": "Y a-t-il un lien entre l'alimentation et Wnt-5a ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses peut influencer négativement l'expression de Wnt-5a." } }, { "@type": "Question", "name": "Le stress chronique impacte-t-il Wnt-5a ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut perturber la régulation de Wnt-5a, augmentant les risques de maladies." } } ] } ] }

Sources (10000 au total)

Effects of decision making and impulsivity on the addictive features of non-suicidal self-injury behaviors in adolescents with depressive disorder.

Non-suicidal self-injury (NSSI) behaviors pose a significant threat to the physical and psychological well-being of adolescents. Recent research suggests that persistent, uncontrollable and repetitive... Using a cross-sectional design, a total of 126 adolescent outpatients and inpatients with a mean age of 15.49 years old (M = 15.49, SD = 1.56), male students (n = 28, 22.2%) and female students (n = 9... The depression with NSSI addictive features group had significantly lower total net scores and net scores of block3, block4, and block5 in the IGT than the depression without NSSI group, whereas there... Adolescents with depressive disorders with NSSI behavioral addictive features had higher severity of depression, exhibited higher cognitive impulsivity, and made more unfavorable decisions when making...

The association between traumatic experiences and substance and behavioral addictions in late adolescence: A role for PTSD and cPTSD as potential mediators.

Traumatic experiences (TEs) are a risk factor for behavioral and substance addictions (SBAs). However, the role of post-traumatic stress disorder (PTSD) and complex PTSD (cPTSD) deserves further eluci... An observational cross-sectional study was conducted on one thousand ten late adolescents (510 males, 498 females; age: mean = 18.7, SD = 0.65). Data regarding intentional (iTEs) and unintentional TEs... uTEs were associated with cannabis use (OR = 1.34 [1.13,1.59]) and alcohol use (OR = 1.21 [1.10,1.35]), iTEs were associated with cannabis use (OR = 1.15 [1.06,1.25]), alcohol use (OR = 1.08 [1.02,1.1... cPTSD and SBAs show a complex pattern of association. A thorough assessment of stress-related conditions, including cPTSD, is of pivotal importance in treating SBAs....

The mediating effect of after-midnight use of digital media devices on the association of internet-related addictive behavior and insomnia in adolescents.

There is evidence that overexposure to digital media devices (DMD) can not only lead to addictive patterns of internet use, but also cause insomnia symptoms. The aim of this cross-sectional study amon... 2,712 school students from Styrian schools participated in a population-representative online survey in a supervised school setting in spring 2022. School students were screened using established and ... Prevalence estimation indicates high proportions of clinically relevant moderate [12.6% (11.3%; 14.1%)] and severe [3.6% (2.9%; 4.4%)] insomnia, with an additional 30.6% (29.0%; 32.2%) at subthreshold... Although the cross-sectional nature of this study limits causal inference, the results indicate a need for policies, which are already in preparation in Styria as part of a respective action plan....

Introducing and Evaluating the Effectiveness of Online Cognitive Behavior Therapy for Gambling Disorder in Routine Addiction Care: Comparative Cohort Study.

Several treatment-related challenges exist for gambling disorder, in particular at-scale dissemination in health care settings.... This study describes the introduction of a newly developed internet-delivered cognitive behavioral therapy (iCBT) program for gambling disorder (GD), provided with therapist support in routine addicti... The study site was the Stockholm Addiction eClinic, which offers digital interventions for addictive disorders in routine care. The iCBT program was introduced nationally for treatment-seeking patient... A statistically significant reduction in the Gambling Symptom Assessment Scale scores during the treatment was observed (B=-1.33, SE=0.17, P<.001), corresponding to a large within-group Cohen d effect... A lack of randomized allocation notwithstanding, the iCBT program for GD evaluated in this study was well-received by patients in routine addiction care, was associated with the expected symptom decre... RR2-10.1186/s40814-020-00647-5....